Gainers & Losers
Tue Jul 08 2025 10:28:40- Kotak Mahindra Bank share price
- ₹2,224.503.61%
- Asian Paints share price
- ₹2,484.601.69%
- Ntpc share price
- ₹343.201.64%
- State Bank Of India share price
- ₹812.800.72%
- Hdfc Bank share price
- ₹2,001.500.72%
Active Stocks
Tue Jul 08 2025 10:29:07- Hdfc Bank share price
- ₹2,001.500.72%
- Reliance Industries share price
- ₹1,538.80-0.16%
- Tata Motors share price
- ₹693.250.64%
- Ntpc share price
- ₹343.201.64%
- Zee Entertainment Enterpri...
- ₹145.650.45%
Business News/Market/Market Stats/Glaxosmithkline Pharmaceutical share price/ Glaxosmithkline Pharmaceutical Profit Loss Annual
Glaxosmithkline Pharmaceutical Profit & Loss Annual
3,271.10 -10.55 (-0.32%)Updated : 08 Jul 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 2,636.37 | 2,778.00 | 2,513.91 | 2,599.03 |
| Other Net | 4.77 | 4.85 | -0.37 | 3.45 |
| Diluted Weighted Average Shares | 16.94 | 16.94 | 16.94 | 16.94 |
| Gain( Loss)on Saleof Assets | 4.69 | 20.58 | 9.67 | 31.72 |
| Depreciation/ Amortization | 66.66 | 69.54 | 65.62 | 68.04 |
| Operating Income | 1,112.84 | 675.71 | 737.81 | 679.00 |
| Net Income | 927.58 | 589.96 | 610.69 | 1,694.72 |
| Income Availableto Com Excl Extra Ord | 927.58 | 589.96 | 607.64 | 380.77 |
| Other Operating Expenses Total | 60.64 | 61.01 | 52.24 | 47.06 |
| Net Income Before Taxes | 1,259.88 | 816.19 | 836.40 | 779.05 |
| Interest Exp( Inc) Net- Operating Total | 0.13 | 0.14 | 0.14 | 0.14 |
| Net Income After Taxes | 927.58 | 589.96 | 607.64 | 380.77 |
| Income Availableto Com Incl Extra Ord | 927.58 | 589.96 | 610.69 | 1,694.72 |
| Costof Revenue Total | 1,512.30 | 1,457.10 | 1,394.28 | 1,482.14 |
| Gross Profit | 2,236.91 | 1,996.61 | 1,857.44 | 1,795.89 |
| Interest Inc( Exp) Net- Non- Op Total | 137.58 | 115.05 | 89.29 | 64.87 |
| Diluted Net Income | 927.58 | 589.96 | 610.69 | 1,694.72 |
| DPS- Common Stock Primary Issue | 42.00 | 32.00 | 32.00 | 30.00 |
| Provisionfor Income Taxes | 332.30 | 226.23 | 228.76 | 398.28 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 927.58 | 589.96 | 607.64 | 380.77 |
| Total Revenue | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 |
| Selling/ General/ Admin Expenses Total | 996.64 | 1,026.91 | 991.00 | 981.81 |
| Diluted Normalized EPS | 54.55 | 40.92 | 35.91 | 22.13 |
| Diluted EPS Excluding Extra Ord Items | 54.76 | 34.83 | 35.87 | 22.48 |
| Total Extraordinary Items | - | 0.00 | 3.04 | 1,313.95 |
| Unusual Expense( Income) | - | 163.30 | 10.61 | 19.82 |
*All figures in crores except per share values
Glaxosmithkline Pharmaceutical Quick Links
Glaxosmithkline Pharmaceutical Dividend Glaxosmithkline Pharmaceutical Bonus Glaxosmithkline Pharmaceutical News Glaxosmithkline Pharmaceutical AGM Glaxosmithkline Pharmaceutical Rights Glaxosmithkline Pharmaceutical Splits Glaxosmithkline Pharmaceutical Board Meetings Glaxosmithkline Pharmaceutical Key Metrics Glaxosmithkline Pharmaceutical Shareholdings Glaxosmithkline Pharmaceutical Balance Sheet Glaxosmithkline Pharmaceutical Cashflow Glaxosmithkline Pharmaceutical Q1 Results Glaxosmithkline Pharmaceutical Q2 Results Glaxosmithkline Pharmaceutical Q3 Results Glaxosmithkline Pharmaceutical Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,224.50+77.50(3.61%)
2,484.60+41.20(1.69%)
343.20+5.55(1.64%)
3,440.60-226.25 (-6.17%)
1,165.40-10.05 (-0.85%)